Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

IVUS vs iFR for Left Main Decision Making

No decision on the coronary tree has more impact than left main intervention. This makes interventionists prone to over and underestimation of angiographic imaging. In other words, in real life we never report on angiograms showing moderate left main lesions.  

IVUS vs OCT para guiar la angioplastia ¿Cuál elegir?

This reality should be looked into, since operating or intervening moderate left main lesions on a suspicious angiographic imaging doesn’t come free. 

Interobserver variability was created when intravascular ultrasound (IVUS) started being published. The 6 mm2 minimal luminal cutoff area by IVUS resulted effective for revascularization decision making. 

These studies offered an objective solution, but also raised a few questions. The cutoff value is an absolute number that does not take into account vessel reference diameter, or patient body surface area. A small woman can have < 6 mm2 luminal area in a perfectly healthy left main. 

These were  the questions  behind the present study, published in Circulation, to assess the use of iFR in the assessment of angiographically intermediate left main lesions.

It included 125 patients assessed with iFR and IVUS. Researchers identified iFR ≤0.89 correlates well with minimal luminal area < 6 mm2. This cutoff value has and area under the curve of 0.77 (77% sensitivity and 66% specificity; p<0.0001).

69 patients with no anterior descending or circumflex ostial lesions showed and area under the curve of 0.84 (70% sensitivity and 84% specificity; p<0.0001).


Read also: Which Type 2 Endoleaks Should We Intervene?


This correlation was not influenced when considering patient body surface. 

This is a good correlation; however, it does not seem enough for a left main lesion. Besides, IVUS not only is useful for diagnosing, but also for strategy planning and angiogram outcome optimization. 

It the therapeutic decision were myocardial revascularization and there were other lesions to assess, we might be tempted to use iFR. However, there is evidence showing lesion functional assessment is not useful when it comes to surgical revascularization. 

Conclusion

Instantaneous wave-free ratio (iFR) ≤0.89 correlated well with minimal luminal area < 6 mm2 by intravascular ultrasound imaging (IVUS)in intermediate left main lesions. This was true regardless patient body surface. 

Original Title: Correlation of Intravascular Ultrasound and Instantaneous Wave-Free Ratio in Patients With Intermediate Left Main Coronary Artery Disease.

Reference: Circ Cardiovasc Interv. 2021 Jun;14(6):e009830. doi: 10.1161/CIRCINTERVENTIONS.120.009830.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...